Pancreatic Cancer Research

Journal articleMelanoma Res2018

CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer.

Journal
Melanoma Res
Published
1 June 2018
Citations
6
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

CDKN2A germline mutations increase the risk of melanoma development and are present in 20 and 10% of familial and multiple melanoma cases, respectively. Pancreatic cancer has been associated with CDKN2A in some populations and, accordingly, its presence in first-degree or second-degree relatives of a melanoma patient is considered as a criterion for genetic testing. … Excerpt only: this text is the publisher’s. Read it in full at the source.